NCT05198466View on ClinicalTrials.gov

Electrical Stimulation for Critically Ill Post-Covid-19 Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

August 18, 2021

Primary Completion Date

August 18, 2022

Study Completion Date

August 18, 2022

Conditions
COVID-19Muscle AtrophyMuscle Weakness
Interventions
DEVICE

Electrical Stimulation

Subjects will receive an active electrical stimulation device to wear for 1 hour daily for 4 weeks (phase II).

DEVICE

Electrical Stimulation - Sham

Subjects will receive a sham electrical stimulation device to wear for 1 hour daily for 4 weeks (phase II).

Trial Locations (1)

77030

Baylor College of Medicine, Houston

All Listed Sponsors
collaborator

Avazzia, Inc

INDUSTRY

lead

Baylor College of Medicine

OTHER

NCT05198466 - Electrical Stimulation for Critically Ill Post-Covid-19 Patients | Biotech Hunter | Biotech Hunter